Antidepressants are the most commonly prescribed psychiatric medication but concern has been raised about significant increases in their usage in high income countries. We aimed to quantify antidepressant prevalence, incidence, adherence and predictors of use in the adult population.
Methods:
The study record-linked administrative prescribing and morbidity data to the Generation Scotland cohort (N = 11,052), between 2009 and 2016. Prevalence and incidence of any antidepressant use was determined. Antidepressant adherence was measured using Proportion of Days Covered and Medication Possession Ratio. Time-to-event analysis for incident antidepressant use within 5 years of Generation Scotland: Scottish Family Health Study (GS:SFHS) recruitment was performed to reveal patient-level predictors of use.
Results:
Almost one-third (28.0%, 95%CI 26.9–29.1) of the adults in our sample were prescribed at least one antidepressant in the 5-year period 2012–2016. There was a 36.2% increase in annual prevalence between 2010 and 2016. Incidence was 2.4(2.1–2.7)% per year. The majority of antidepressant episodes (57.6%) were greater than 9 months duration and adherence was generally high (69.0% with Proportion of Days Covered >80%). Predictors of new antidepressant use included history of affective disorder, being female, physical comorbidities, higher neuroticism scores, and lower cognitive function scores.
Conclusions:
Antidepressant prevalence is greater than previously reported but incidence remains relatively stable. We found the majority of antidepressant episodes to be of relatively long duration with good estimated adherence. Our study supports the hypothesis that increased long-term use among existing (and returning) users, along with wider ranges of indications for antidepressants, has significantly increased the prevalence of these medications.
Abbing-KarahagopianVHuertaCSouvereinPet al. (2014) Antidepressant prescribing in five European countries: Application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol70: 849–857.
2.
AlonsoJ AMBernertSet al. (2004) Prevalence of mental disorders in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl420: 21–27.
3.
Alvarez-MadrazoSMcTaggartSNangleCet al. (2016) Data resource profile: The Scottish national prescribing information system (PIS). Int J Epidemiol45: 714–715.
4.
BandelowBMichaelisS (2015) Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci17: 327–335.
5.
BetPMHugtenburgJGPenninxBWet al. (2013) Side effects of antidepressants during long-term use in a naturalistic setting. Eur Neuropsychopharmacol23: 1443–1451.
6.
BosmanRCHuijbregtsKMVerhaakPFet al. (2016) Long-term antidepressant use: A qualitative study on perspectives of patients and GPs in primary care. Br J Gen Pract66: e708–e719.
7.
CiprianiAFurukawaTASalantiGet al. (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. Lancet391: 1357–1366.
8.
CouplandCDhimanPMorrissRet al. (2011) Antidepressant use and risk of adverse outcomes in older people: Population based cohort study. BMJ343: d4551.
9.
CouplandCHillTMorrissRet al. (2015) Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: Cohort study using a primary care database. BMJ350: h517.
10.
CruickshankGMacgillivraySBruceDet al. (2008) Cross-sectional survey of patients in receipt of long-term repeat prescriptions for antidepressant drugs in primary care. Ment Health Fam Med5: 105–109.
11.
ExeterDRobinsonEWheelerA (2009) Antidepressant dispensing trends in New Zealand between 2004 and 2007. Aust N Z J Psychiatry43: 1131–1140.
12.
EysenckSBEysenckHJ (1964) An improved short questionnaire for the measurement of extraversion and neuroticism. Life Sci3: 1103–1109.
13.
EysenckSBEysenckHJBarrettP (1985) A revised version of the psychoticism scale. Pers Individ Dif6: 21–29.
14.
GardarsdottirHSouvereinPCEgbertsTCet al. (2010) Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. J Clin Epidemiol63: 422–427.
15.
GoldbergDPHillierVF (1979) A scaled version of the General Health Questionnaire. Psychol Med9: 139–145.
16.
Gonzalez-LopezMCRodriguez-LopezCMParron-CarrenoTet al. (2015) Trends in the dispensation of antidepressant drugs over the past decade (2000–2010) in Andalusia, Spain. Soc Psychiatry Psychiatr Epidemiol50: 705–712.
17.
GowAWhitemanMPattieAet al. (2005) Goldberg‘s IPIP‘Big-Five factor markers: Internal consistency and concurrent validation in Scotland. Pers Individ Dif39: 317–329.
HillTCouplandCMorrissRet al. (2015) Antidepressant use and risk of epilepsy and seizures in people aged 20 to 64 years: Cohort study using a primary care database. BMC Psychiatry15: 315.
20.
HollinghurstSKesslerDPetersTJet al. (2005) Opportunity cost of antidepressant prescribing in England: Analysis of routine data. BMJ330: 999–1000.
21.
HuijbregtsKMHoogendoornASlottjePet al. (2017) Long-term and short-term antidepressant use in general practice: Data from a large cohort in the Netherlands. Psychother Psychosom86: 362–369.
22.
IlyasSMoncrieffJ (2012) Trends in prescriptions and costs of drugs for mental disorders in England, 1998 −2010. Br J Psychiatry200: 393–398.
23.
JohnsonCFMacdonaldHJAtkinsonPet al. (2012) Reviewing long-term antidepressants can reduce drug burden: A prospective observational cohort study. Br J Gen Pract62: e773–e779.
24.
Joint Formulary Committee (2012) British National Formulary. London and Chicago: Pharmaceutical Press.
25.
KendrickTKingFAlbertellaLet al. (2005) GP treatment decisions for patients with depression: An observational study. Br J Gen Pract55: 280–286.
26.
KendrickTStuartBNewellCet al. (2015) Did NICE guidelines and the Quality Outcomes Framework change GP antidepressant prescribing in England? Observational study with time trend analyses 2003–2013. J Affect Disord186: 171–177.
27.
KesslerDSharpDLewisG (2005) Screening for depression in primary care. Br J Gen Pract55: 659–660.
28.
KeylounKRHansenRNHeppZet al. (2017) Adherence and persistence across antidepressant therapeutic classes: A retrospective claims analysis among insured US patients with Major Depressive Disorder (MDD). CNS Drugs31: 421–432.
29.
KirschIDeaconBJHuedo-MedinaTBet al. (2008) Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration. PLoS Med5: 260–268.
30.
LewerDO’ReillyCMojtabaiRet al. (2015) Antidepressant use in 27 European countries: Associations with sociodemographic, cultural and economic factors. Br J Psychiatry207: 221–206.
31.
LezakM (1995) Neuropsychological Testing. Oxford: Oxford University Press.
32.
LockhartPGuthrieB (2011) Trends in primary care antidepressant prescribing 1995–2007: A longitudinal population database analysis. Br J Gen Pract61: e565–e572.
33.
MarazzitiDConsoliGPicchettiMet al. (2010) Cognitive impairment in major depression. Eur J Pharmacol626: 83–86.
34.
MarioniREBattyGDHaywardCet al. (2014) Common genetic variants explain the majority of the correlation between height and intelligence: The generation Scotland study. Behav Genet44: 91–96.
35.
MarsBHeronJKesslerDet al. (2017) Influences on antidepressant prescribing trends in the UK: 1995–2011. Soc Psychiatry Psychiatr Epidemiol52: 193–200.
36.
McIntoshAMHallLSZengYet al. (2016) Genetic and environmental risk for chronic pain and the contribution of risk variants for major depressive disorder: A family-based mixed-model analysis. PLoS Med13: e1002090.
37.
MeijerWEHeerdinkERLeufkensHGet al. (2004) Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol60: 57–61.
38.
MojtabaiROlfsonM (2014) National trends in long-term use of antidepressant medications: Results from the US National Health and Nutrition Examination Survey. J Clin Psychiatry75: 169–177.
39.
MooreMYuenHMDunnN (2009) Explaining the rise in antidepressant prescribing: A descriptive study using the general practice research database. BMJ339: b3999.
40.
Munoz-ArroyoRSuttonMMorrisonJ (2006) Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data. Br J Gen Pract56: 423–428.
OlfsonMMarcusSC (2009) National patterns in antidepressant medication treatment. Arch Gen Psychiatry66: 848–856.
45.
PettyDRHouseAKnappPet al. (2006) Prevalence, duration and indications for prescribing of antidepressants in primary care. Age Ageing35: 523–526.
46.
PrattLABrodyDJGuQ (2011) Antidepressant use in persons aged 12 and over: United States, 2005–2008. NCHS Data Brief1–8.
47.
RaineA (1991) The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull17: 555–564.
48.
RaymondCBMorganSGCaetanoPA (2007) Antidepressant utilization in British Columbia from 1996 to 2004: Increasing prevalence but not incidence. Psychiatr Serv58: 79–84.
49.
ReidI (2013) Are antidepressants overprescribed?BMJ346: f190.
50.
Scottish Government (2009) Scottish Index of Multiple Deprivation 2009 General Report. Edinburgh: Office of the Chief Statistician.
51.
Scottish Government (2011) Scotland Census 2011. Edinburgh: National Records of Scotland. Available at: https://www.scotlandscensus.gov.uk/ (accessed 4 February 2019).
52.
SmithBHCampbellALinkstedPet al. (2013) Cohort profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. Int J Epidemiol42: 689–700.
53.
SmithBHCampbellHBlackwoodDet al. (2006) Generation Scotland: The Scottish Family Health Study; a new resource for researching genes and heritability. BMC Med Genet7: 74.
54.
SmithDJEscott-PriceVDaviesGet al. (2016) Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci. Mol Psychiatry21: 1644.
55.
SpenceD (2013) Are antidepressants overprescribed?BMJ346: f191.
56.
SpenceRRobertsAAritiCet al. (2014) Focus On: Antidepressant Prescribing: Trends in the Prescribing of Antidepressants in Primary Care. London: The Health Foundation and the Nuffield Trust.
57.
SteffensDCWuRGradyJJet al. (2018) Presence of neuroticism and antidepressant remission rates in late-life depression: Results from the Neurobiology of Late-Life Depression (NBOLD) study. Int Psychogeriatr30: 1069–1074.
58.
SwallowBLMassonSWHayE (2003) The use of the General Health Questionnaire (GHQ-28) to estimate prevalence of psychiatric disorder in early pregnancy. Psychol Health Med8: 213–217.
59.
TrifiroGBarbuiCSpinaEet al. (2007) Antidepressant drugs: Prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003–2004. Pharmacoepidemiol Drug Saf16: 552–559.
60.
van BuurenS (2012) Flexible Imputation of Missing Data. Boca Raton, FL: Chapman and Hall.
61.
WangPSLaneMOlfsonMet al. (2005) Twelve-month use of Mental Health Services in the United States – Results from the National Comorbidity Survey Replication. Arch Gen Psychiatry62: 629–640.
62.
WechslerD (1998a) Wechsler Adult Intelligence Scale III. London: Psychological Corporation.
63.
WechslerD (1998b) Wechsler Memory Scale III. London: Psychological Corporation.
64.
World Health Organisation (2011) World Health Organisation Collaborating Centre for Drug Statistics ATC/DDD Index 2011. Oslo: World Health Organisation /Norwegian Institute of Public Health.
ZhongWJKremersHMYawnBPet al. (2014) Time trends of antidepressant drug prescriptions in men versus women in a geographically defined US population. Arch Womens Ment Health17: 485–492.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
